Viatris (VTRS) Cash from Investing Activities (2019 - 2026)

Viatris (VTRS) recorded quarterly Cash from Investing Activities of $277.4 million in Q1 2026, up 231.34% quarter-over-quarter from -$211.2 million in Q4 2025, and up 526.11% on a YoY basis from $44.3 million in Q1 2025.

Viatris (VTRS) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Viatris' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $277.4 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 526.11% year-over-year to $277.4 million; the TTM figure through Mar 2026 stood at -$85.2 million (down 104.51% YoY), while the FY2025 annual figure was -$427.7 million, down 123.75% from the prior year.
  • Cash from Investing Activities was $277.4 million for Q1 2026 at Viatris, up from -$211.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.7 billion in Q3 2024 to a low of -$749.5 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged $132.9 million across 5 years, with a median of -$66.9 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities sank 1020.33% in 2023, then soared 3283.79% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $1.7 billion in 2022, then sank by 98.46% to $26.7 million in 2023, then tumbled by 731.84% to -$168.7 million in 2024, then fell by 25.19% to -$211.2 million in 2025, then surged by 231.34% to $277.4 million in 2026.
  • The last three Cash from Investing Activities figures came in at $277.4 million (Q1 2026), -$211.2 million (Q4 2025), and -$98.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Viatris - - 1.16 Bn 277.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 277.40 Mn
Mar 31, 2026 277.40 Mn
Dec 31, 2025 -211.20 Mn
Dec 31, 2025 -211.20 Mn
Sep 30, 2025 -98.90 Mn
Sep 30, 2025 -98.90 Mn
Jun 30, 2025 -52.50 Mn
Jun 30, 2025 -52.50 Mn
Mar 31, 2025 -65.10 Mn
Mar 31, 2025 -65.10 Mn
Dec 31, 2024 -168.70 Mn
Dec 31, 2024 -168.70 Mn
Sep 30, 2024 1.75 Bn
Sep 30, 2024 1.75 Bn
Jun 30, 2024 375.80 Mn
Jun 30, 2024 375.80 Mn
Mar 31, 2024 -154.30 Mn
Mar 31, 2024 -154.30 Mn
Dec 31, 2023 26.70 Mn
Dec 31, 2023 26.70 Mn